Mental Health by the Numbers FAQs
Frequently Asked Questions
Tell us what you're looking for to find questions and answers about your topic.
Recent FAQs
Airborne Hazards and Open Burn Pit Registry: Eligibility and Enrollment
Airborne Hazards and Open Burn Pit Registry: General Information
Individual Longitudinal Exposure Record
MHS Modified Payment and Waiver Program: Overseas Information
MHS Modified Payment and Waiver Program: Implementation Timeline
MHS Modified Payment and Waiver Program: Billing Delays
MHS Modified Payment and Waiver Program: Eligibility Requirements
MHS Modified Payment and Waiver Program: General Questions
Defense Health Agency Graduate Medical Education Application Information: Military Medical School Funding Options
We found 857 items
DOD P&T Committee Executive Summary: Ophthalmic Immunomodulatory Agents Cyclosporine 0.05% Ophthalmic Emulsion (Restasis)
DOD Subclass Review: Ophthalmic Immunomodulatory Agents: Restatis February 2016
DOD P&T Committee Executive Summary: Topical Antifungal Drugs for Onychomycosis
DOD Subclass Review: Topical Antifungal Drugs for Onychomycosis Feb. 2016
P&T Minutes - February 2016
P&T Committee Meeting minutes for February 2016
BAP Background Information: April 6, 2016
Meeting Materials for the 6 APR 16 UF BAP meeting.
BAP Handout: April 6, 2016
Meeting Materials for the 6 April 16 UF BAP Meeting
BAP Agenda: April 6, 2016
Meeting Materials for the 6 APR UF BAP Meeting
BAP Meeting Minutes: April 6, 2016
Meeting Minutes for the April 6, 2016 Beneficiary Advisory Panel
Minutes: Pre-Proposal Conference for UF BPA/VARR Covering Quotes of the May 2016 DoD P&T Committee Meeting
These are the meeting minutes for the Pre-Proposal Conference for UF BPA/VARR Covering Quotes of the May 2016 DoD P&T Committee Reviews
Agenda: Feb. 10, 2016
Agenda for the Defense Health Board Feb. 10, 2016 meeting.
Minutes: February 10-11, 2016
Minutes from the DHB meeting on February 10-11, 2016
Meeting Minutes: Beneficiary Advisory Panel, Jan. 7, 2016
Meeting Minutes for the Jan. 7, 2016 Beneficiary Advisory Panel
P&T Minutes - Nov. 2015
Minutes for the DOD P&T Committee Meeting from Nov. 2015
DoD P&T Committee Executive Summary: Chronic Myelogenous Leukemia
DoD Class Review: Chronic Myelogenous Leukemia Drugs, August 2015
DoD P&T Committee Executive Summary: Glucagon-Like Peptide-1 Receptors Agonist (GLP1RA)
DoD Subclass Review: DoD Subclass Review: Glucagon-Like Peptide-1 Receptor Agonists August 2015
DoD P&T Committee Executive Summary: Extended Release Opioids
DoD Subclass Review: Extended Release High Potency Opioids, August 2015
The appearance of hyperlinks does not constitute endorsement by the Department of Defense of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.
You are leaving Health.mil View the external links disclaimer.